What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.53%Above 5Y avg (2.09%)
Annual Rate
CNY 3.40Paid annual
Payout Ratio
112.4%High
Payback Period
26.7 yr
Last Ex-Dividend
Jul 17, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
50.90BCNY
7.55B · vs all stocks (USD)
Updated Aug 18, 2026
Trailing P/E
18.64x
Updated Aug 18, 2026
Revenue (TTM)
17.13BCNY
2.54B · vs all stocks (USD)
Updated Aug 18, 2026
Profit Margin
16.50%
Updated Aug 18, 2026
Beta
0.1550x
vs all stocks
Updated Aug 18, 2026
52-Week Change
-40.30%
vs all stocks
Updated Aug 18, 2026
Market Capitalization
50.90BCNY
7.55B · vs all stocks (USD)
Updated Aug 18, 2026
Enterprise Value
37.22BCNY
5.52B · vs all stocks (USD)
Updated Aug 18, 2026
Trailing P/E
18.64x
Updated Aug 18, 2026
Forward P/E
12.24x
Updated Aug 18, 2026
Price to Sales (TTM)
2.93x
Updated Aug 18, 2026
Price to Book (MRQ)
1.92x
Updated Aug 18, 2026
Enterprise to Revenue
2.17x
Updated Aug 18, 2026
Enterprise to EBITDA
7.96x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 6.01×.Updated Aug 18, 2026
Gross Margin
77.85%
Updated Aug 18, 2026
Profit Margin
16.50%
Updated Aug 18, 2026
Operating Margin
28.12%
Updated Aug 18, 2026
Return on Assets (TTM)
5.84%
Updated Aug 18, 2026
Return on Equity (TTM)
10.62%
Updated Aug 18, 2026
Revenue (TTM)
17.13BCNY
2.54B · vs all stocks (USD)
Updated Aug 18, 2026
Revenue per Share (TTM)
32.38CNYUpdated Aug 18, 2026
Quarterly Revenue Growth
-18.60%
Updated Aug 18, 2026
Gross Profit (TTM)
13.36BCNY
1.98B · vs all stocks (USD)
Updated Aug 18, 2026
EBITDA (TTM)
6.19BCNY
918.40M · vs all stocks (USD)
Updated Aug 18, 2026
Net Income (TTM)
2.83BCNY
419.12M · vs all stocks (USD)
Updated Aug 18, 2026
Quarterly Earnings Growth (YoY)
-31.00%
Updated Aug 18, 2026
Operating Cash Flow (TTM)
2.01BCNY
298.59M · vs all stocks (USD)
Updated Aug 18, 2026
Levered Free Cash Flow (TTM)
-38.91MCNY
-5.77M · vs all stocks (USD)
Updated Aug 18, 2026
Trailing Annual Dividend Rate
3.40CNYUpdated Aug 18, 2026
Trailing Annual Dividend Yield
3.53%
vs all stocks
Updated Aug 18, 2026
5-Year Average Dividend Yield
2.09%
vs all stocks
Updated Aug 18, 2026
Payout Ratio
112.36%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 66.67%.Updated Aug 18, 2026
Minority Interest (Equity)
1.05BCNYFY2025 · Dec 31, 2025
Revenue
18.83BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
3.91BCNYFY2025 · Dec 31, 2025
Gross Profit
14.93BCNYFY2025 · Dec 31, 2025
Operating Income
4.88BCNY
724.34M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
5.08BCNYFY2025 · Dec 31, 2025
Income Tax Expense
1.44BCNYFY2025 · Dec 31, 2025
Net Income
3.64BCNYFY2025 · Dec 31, 2025
EBIT
5.09BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
6.19BCNYFY2025 · Dec 31, 2025
Research & Development
88.19MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
4.67BCNYFY2025 · Dec 31, 2025
Other Operating Expenses
3.17BCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
538.06MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
10.59MCNYFY2025 · Dec 31, 2025
EPS (Basic)
6.71CNYFY2025 · Dec 31, 2025
EPS (Diluted)
6.71CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
528.93MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
528.93MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
3.64BCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-91.41MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
4.49BCNYFY2025 · Dec 31, 2025
Free Cash Flow
2.83BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
12.49BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
3.64BCNYFY2025 · Dec 31, 2025
Other Non-cash Items
57.77MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
2.27BCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-1.47BCNYFY2025 · Dec 31, 2025
Capital Expenditures
-1.66BCNYFY2025 · Dec 31, 2025
Purchase of Investments
-7.15BCNYFY2025 · Dec 31, 2025
Sale of Investments
7.06BCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-1.75BCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
449.72MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-129.39MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-3.18BCNYFY2025 · Dec 31, 2025
Other Financing Charges
-1.38MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-2.86BCNYFY2025 · Dec 31, 2025
Shares Outstanding
528.60MSharesUpdated Aug 18, 2026
Float Shares
257.20MSharesUpdated Aug 18, 2026
% Held by Insiders
66.42%
vs all stocks
Updated Aug 18, 2026
% Held by Institutions
16.24%
vs all stocks
Updated Aug 18, 2026
Total Cash (MRQ)
14.72BCNY
2.18B · vs all stocks (USD)
Updated Aug 18, 2026
Total Cash per Share (MRQ)
27.84CNYUpdated Aug 18, 2026
Total Debt (MRQ)
593.90MCNY
88.08M · vs all stocks (USD)
Updated Aug 18, 2026
Total Debt to Equity (MRQ)
0.0218x
Updated Aug 18, 2026
Current Ratio (MRQ)
2.30x
Updated Aug 18, 2026
Book Value per Share (MRQ)
49.42CNYUpdated Aug 18, 2026
Total Assets
38.20BCNY
5.66B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
26.43BCNYFY2025 · Dec 31, 2025
Total Liabilities
12.09BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
11.77BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
808.40MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
11.28BCNYFY2025 · Dec 31, 2025
Cash
14.15BCNYFY2025 · Dec 31, 2025
Cash Equivalents
36.01MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
14.19BCNYFY2025 · Dec 31, 2025
Accounts Receivable
54.00MCNYFY2025 · Dec 31, 2025
Inventory
10.74BCNYFY2025 · Dec 31, 2025
Accounts Payable
3.78BCNYFY2025 · Dec 31, 2025
Short-term Debt
246.08MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
1.04BCNYFY2025 · Dec 31, 2025
Long-term Debt
336.34MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
528.60MCNYFY2025 · Dec 31, 2025
Retained Earnings
18.02BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
26.10BCNY
3.87B · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
75.20CNYUpdated Aug 18, 2026
52-Week High
177.01CNYUpdated Aug 18, 2026
52-Week Change
-40.30%
vs all stocks
Updated Aug 18, 2026
Beta
0.1550x
vs all stocks
Updated Aug 18, 2026
50-Day MA
86.83CNYUpdated Aug 18, 2026
200-Day MA
115.63CNYUpdated Aug 18, 2026
Avg 10-Day Volume
8.26MSharesUpdated Aug 18, 2026
Avg 30-Day Volume
8.11MSharesUpdated Aug 18, 2026
Diluted EPS (TTM)
5.10CNYUpdated Aug 18, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.59: safe zoneNotable
Altman Z-Score: 4.59
Supply Chain
Upstream position: supplies 6 industries, depends on 0Notable
Outgoing: 6.00Incoming: 0.00
Scale
Market cap is $7.55B, above the global median of $1.15BNotable
Market cap (USD): 7,549,089,894Global Median: 1,146,734,693.424
Revenue is $2.54B, above the global median of $520.53MNotable